Axogen's Avance Nerve Graft Achieves Historic FDA Biologics License Approval

Eli Lilly's Jaypirca Secures Full FDA Approval, Offering New Hope for Certain Blood Cancers

Citius Oncology's Lymphir: A New Chapter in the Fight Against Cutaneous T-Cell Lymphoma

A New Dawn for Skin Cancer Patients: Citius Oncology Launches Lymphir in the US

A Game-Changer for Kids' Eyes: New FDA-Approved Glasses Tackle Nearsightedness Head-On

A Welcome Return: FDA Gives Green Light to Reformulated Ranitidine (Zantac) After Major Recall

A New Horizon for SMA Patients: Novartis's Groundbreaking Gene Therapy Gets FDA Nod

Novartis Shares Soar as FDA Gives Landmark Nod to Zolgensma Gene Therapy for Teens and Adults

A New Horizon for Bladder Cancer Patients: FDA Approves Keytruda-Padcev Combo as First-Line Therapy

The Sound Revolution: Your AirPods Just Became So Much More Than Headphones

The Siren Song of 'Secret' Serums: Why Influencer-Pushed Peptides Could Be Perilous

A New Chapter for Little Stomachs: Ironwood's Linzess Opens Doors for Pediatric IBS Relief

A Breath of Fresh Air for Kids Living with IBS-C

The Zynity Enigma: When Innovation Meets Intense Scrutiny at the FDA

The High Stakes Game: Sarepta, Duchenne, and the Edge of Hope

The Tug-of-War Over Abortion Pill Access: New York Fights Back Against Texas Ruling

The Game Changer? America's FDA Just Gave the Nod to an Oral Weight Loss Drug, But What's the Catch?

A Bittersweet Wait: Immuron's Travelan Data Faces an Unexpected Delay

Unlocking Access: The FDA's Bold Move to Fast-Track Life-Saving Biosimilars

A Cruel Twist of Fate: Alzheimer's Hope Dawns, But Not for Everyone — Yet.

A New Dawn for Menopause Relief: The Non-Hormonal Breakthrough That Could Change Everything

A New Dawn: Reclaiming Comfort from Menopause's Fiery Grip

Turning the Tide on Menopause: A Groundbreaking Hormone-Free Treatment Arrives

A Fresh Start for Relief: The FDA Greenlights Another Non-Hormonal Option for Menopause's Hottest Moments

The Heat is On... And Now, Perhaps, Off? A New FDA Approval for Menopause Relief

A New Dawn of Relief: Tackling Menopause Hot Flashes with a Fresh Approach

The Weekend's Big Buzz: Why Syndax Pharmaceuticals Just Shot for the Stars

A New Dawn for Bladder Cancer Patients: Astellas & Pfizer's Combination Therapy Halves Mortality Risk

FDA Approves Tezspire Self-Administration, Revolutionizing Severe Asthma Care for Amgen and AstraZeneca

Trump's Bold Pledge: Revolutionizing IVF Access with Drug Discounts and Expanded Fertility Benefits

Trump's Bold Initiative: Making IVF Affordable and Accessible for American Families

FDA Greenlights Groundbreaking Blood Test for Alzheimer's Disease

A New Era for Alzheimer's Diagnosis: FDA Approves First Blood Test

A New Dawn for Diagnostics: FDA Approves First Blood Test for Alzheimer's Disease

A New Dawn for Alzheimer's Diagnosis: FDA Approves Roche and Eli Lilly's Groundbreaking Blood Test

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

A New Era for Bipolar I Treatment: Teva's UZEDY Gains Crucial FDA Approval

A New Dawn for Bladder Control: Medtronic's Altaviva and BlueWind's Revi Promise Life-Changing Freedom

Game-Changer for Seniors: IceCure's ProSense Revolutionizes Breast Cancer Treatment for Women Over 70